About us
About Lever Bio
Lever Bio partners with top researchers to exploit cutting-edge biology and address unmet medical needs. Promoted by Claris Ventures and Exor Ventures, Lever Bio operates at the intersection between science and innovation, with a commitment to accelerating the translation of groundbreaking discoveries into impactful therapeutics. At Lever Bio, we believe in fostering collaboration and synergy between researchers, universities and research centers to drive drug discovery forward.
_edited.png)
Our Vision
To unlock biotech innovation via early partnering to ultimately improve patient outcomes
Our mission is to fund and support early-stage drug development programs, providing the necessary resources and expertise to advance promising projects from discovery to preclinical stages. Through global business development network and extensive experience in drug development, Lever Bio aims to be the premier partner for researchers seeking to translate biological insights into therapeutic solutions.
Our Mission
Our Partnering Approach
Focusing on synergies and resource optimization, each partnered program will be supported by Lever Bio with an initial budget of up to €500k to progress as close as possible to a nominated preclinical candidate. We prioritize projects with validated targets in areas of high medical need and we are primarily interested in science originating from Italian research centers or Italian researchers based outside Italy.